NASDAQ : BRTX

BioRestorative Therapies, Inc.

$0.347 USD

$0.0 (-1.08%)

Volume
97.23K
Average Volume
10.61M
Market Capitalization
$3.12M
P/E Ratio
-0.28
Dividend Yield
0.00%
Price Target
Year High
$1.89
Year Low
$0.16
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.35
3333332"{? p/.m7yd f,0=

Annual earnings financials

BRTX financial data with annual/quarterly toggle

BRTX GAAP EPS - Annual & Quarterly

BRTX Sales Revenue - Annual & Quarterly

BRTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

BRTX Estimated and Actual Revenue by Quarter
BRTX Estimated and Actual EPS by Quarter
BRTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 -1.63M -396.2K -1.01M -1.63M -396.2K -1.01M
2028-09-30 1 -1.57M -381.52K -975K -1.57M -381.52K -975K
2028-06-30 1 -1.45M -352.17K -900K -1.45M -352.17K -900K
2028-03-31 1 -1.39M -337.5K -862.5K -1.39M -337.5K -862.5K
2027-12-31 1 -1.36M -330.26K -844K -1.36M -330.26K -844K
2027-09-30 1 -1.31M -318.13K -813K -1.31M -318.13K -813K
BRTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 - - - 63.2M 259.83M 161.52M
2028-09-30 1 - - - 60.86M 250.21M 155.54M
2028-06-30 1 - - - 56.18M 230.96M 143.57M
2028-03-31 1 - - - 53.84M 221.34M 137.59M
2027-12-31 1 - - - 52.68M 216.59M 134.64M
2027-09-30 1 - - - 50.75M 208.64M 129.69M
BRTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 396.2K 1.63M 1.01M 0 0 0 0
2028-09-30 1 381.52K 1.57M 975K 0 0 0 0
2028-06-30 1 352.17K 1.45M 900K 0 0 0 0
2028-03-31 1 337.5K 1.39M 862.5K 0 0 0 0
2027-12-31 1 330.26K 1.36M 844K 0 0 0 0
2027-09-30 1 318.13K 1.31M 813K 0 0 0 0